'I am confident that the COVID-19 vaccine will be ready in the next three-four months, ' he said.
Priority is to be given in its distribution and when a vaccine is available, first preference will be given to health workers and people above 65 years of age.
Sao Paulo authorities have not estimated the timing for distribution.
Harsh Vardhan said, "Priority will be given on medical grounds".
Approval of Coronavac will not be concluded before December 21 and could take until the first week of January, Anvisa manager for inspections Ronaldo Gomes told reporters on Wednesday.
In the absence of trade names, the NHS uses codenames to refer to the two vaccine candidates that are expected to be the first available. According to the minister, everything is being decided by experts with a scientific point of view. "By July-August 2021, we will have 400-500 million dosages available".
The government has divided the prioritization under four groups. As you know the healthcare workers who are corona warriors will be prioritised, then people who are above 65 years of age, they have been prioritised and then those from 50-65 years of age have been prioritised. We are a country of 135 crore people, and it's not possible to procure vaccines for such a large population at one go.
Nationally 15,000 volunteers will be needed to take part in the study, as the number of people who have signed up to the NHS Vaccine Registry reaches over 300,000. "Hopefully, 2021 should be a better year for all of us", ANI quoted the health minister as saying. However, there will be no difference for the general public if the vaccine is sold under transit or full permission.
Bharat Biotech Ltd and Indian Council for Medical Research (ICMR) began phase-III trials of Covaxin.
The phase-3 trial of the Oxford vaccine of the Serum Institute is nearly near completion, while the phase-3 clinical trial of the indigenously-developed vaccine candidate of the Bharat Biotech and the Indian Council of Medical Research (ICMR) has already started.
SII has already manufactured 40 million doses of the vaccine, under the at-risk manufacturing and stockpiling license from Drugs Controller General of India (DCGI).
"Between the purchase of new freezers and having that space, in addition to the dry ice shipments, that would probably be able to accommodate ... all the vaccines that we'd be receiving", she said.